ACT

Embryonic stem cells provide limitless source of platelets

A story in yesterday's L.A. Times highlights a point that I think often gets lost in the brouhaha over adult vs. embryonic stem cells. Adult stem cells are great, they really are.

ACT files to test embryonic stem cell-based therapy for macular degeneration

Advanced Cell Technology has filed an application with the FDA to begin an early phase trial of an embryonic stem cell-based therapy for macular degeneration. If the company name sounds familiar, that's because it's the same company that on November 22 received FDA approval to begin a trial for Stargardt's macular degeneration. Both trials are testing the same cells. In a press release, the company said:

Subscribe to RSS - ACT

© 2013 California Institute for Regenerative Medicine